395 related articles for article (PubMed ID: 27490411)
1. Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.
Hart A; Schladt DP; Zeglin J; Pyke J; Kim WR; Lake JR; Roberts JP; Hirose R; Mulligan DC; Kasiske BL; Snyder JJ; Israni AK
Transplantation; 2016 Oct; 100(10):2153-9. PubMed ID: 27490411
[TBL] [Abstract][Full Text] [Related]
2. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
3. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
Trotter JF; Osgood MJ
JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
[TBL] [Abstract][Full Text] [Related]
4. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
5. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard.
Croome KP; Lee DD; Burns JM; Keaveny AP; Taner CB
Liver Transpl; 2018 Apr; 24(4):488-496. PubMed ID: 29365357
[TBL] [Abstract][Full Text] [Related]
6. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
7. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
[TBL] [Abstract][Full Text] [Related]
8. Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.
Tan EK; Goh BKP; Lee SY; Krishnamoorthy TL; Tan CK; Jeyaraj PR
Transplant Proc; 2018 Dec; 50(10):3564-3570. PubMed ID: 30577239
[TBL] [Abstract][Full Text] [Related]
9. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in the United Kingdom.
Neuberger J
Liver Transpl; 2016 Aug; 22(8):1129-35. PubMed ID: 27081833
[TBL] [Abstract][Full Text] [Related]
11. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
12. Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation.
Kwong AJ; Schnellinger E; Foutz J; Cafarella M; Nagai S; Biggins SW; Pomposelli J; Trotter J
Am J Transplant; 2024 Jun; 24(6):1080-1086. PubMed ID: 38408641
[TBL] [Abstract][Full Text] [Related]
13. HCC patients suffer less from geographic differences in organ availability.
Schuetz C; Dong N; Smoot E; Elias N; Schoenfeld DA; Markmann JF; Yeh H
Am J Transplant; 2013 Nov; 13(11):2989-95. PubMed ID: 24011291
[TBL] [Abstract][Full Text] [Related]
14. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
Maduka RC; Abt PL; Goldberg DS
Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
[TBL] [Abstract][Full Text] [Related]
15. [Predictors of mortality among liver transplant candidates].
Erez D; Ben Ari Z; Michowitz R; Mor E
Harefuah; 2011 Jan; 150(1):16-20, 70, 69. PubMed ID: 21449150
[TBL] [Abstract][Full Text] [Related]
16. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
Bababekov YJ; Hung YC; Chang DC; Rickert CG; Adler JT; Bethea E; Pomfret EA; Pomposelli JJ; Yeh H
Transplantation; 2020 Feb; 104(2):280-284. PubMed ID: 31335769
[TBL] [Abstract][Full Text] [Related]
17. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
[TBL] [Abstract][Full Text] [Related]
18. Disparities in liver transplantation before and after introduction of the MELD score.
Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
[TBL] [Abstract][Full Text] [Related]
19. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
20. MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.
Ishaque T; Kernodle AB; Motter JD; Jackson KR; Chiang TP; Getsin S; Boyarsky BJ; Garonzik-Wang J; Gentry SE; Segev DL; Massie AB
Am J Transplant; 2021 Oct; 21(10):3305-3311. PubMed ID: 33870635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
